/
Quality Tolerance Limits
Quality Tolerance Limits
Project Scope |
|
Project Leads | |
Chris Wells, Roche | chris.wells.cw1@roche.com |
Mireille Lovejoy, GE Healthcare | mireille.lovejoy@gehealthcare.com |
Alex Pearce, PHUSE Project Assistant |
CURRENT STATUS Q4 2023 |
---|
|
Objectives & Deliverables | Timelines |
Release of draft White Paper | Q3 2022 |
Publish White Paper | Q3 2023 |
Problem Statement QTLs - the role they play in defining quality within the QbD framework, their relationship to Critical to Quality factors, associated methodologies and the interpretation of them have not been fully defined in clinical development, in particular where early development/small studies, bio equivalence studies and complex designs are concerned. Problem Impact This will impact the whole clinical development process and allow the move away from perfection to a defined and achievable quality, from which continuous quality improvement can begin. |
Terminology Example:
|
, multiple selections available,
Related content
Quality Tolerance Limits – Threshold Setting Methodologies
Quality Tolerance Limits – Threshold Setting Methodologies
More like this
Risk Based Quality Management
Risk Based Quality Management
More like this
Working Group Report – Q3 2024
Working Group Report – Q3 2024
More like this
Enhancing the Clinical Trial Risk Assessment Process
Enhancing the Clinical Trial Risk Assessment Process
More like this